H-D-Met-OH - China Manufacturers, Factory, Suppliers

H-D-Met-OH, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

D-Methionine CAS 348-67-4 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — D-Methionine CAS 348-67-4 (H-D-Met-OH) Assay 99.0%~100.5% Factory
Read More

D-Methionine CAS 348-67-4 (H-D-Met-OH) Assay 99.0%~100.5% Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Top Selling Products

Related Blog
Reviews

Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...

2022.08.09 00:09:43
2022.06.09 14:55:58
2022.05.03 06:14:33
2022.04.27 06:21:09
2021.11.05 05:08:00
2021.10.26 01:33:42

H-D-Met-OH - China Manufacturers, Factory, Suppliers

Related Products

D-Methionine CAS 348-67-4 (H-D-Met-OH) Assay 99.0%~100.5% Factory

D-Methionine CAS 348-67-4 (H-D-Met-OH) Assay 99.0%~100.5% Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Top Selling Products

Triphenylchlorosilane CAS 76-86-8 Purity >98.0% (GC) Factory

Methyl 4-Bromobenzoate CAS 619-42-1 Assay >99.0% (GC) Factory High Quality

HO-EPCP CAS 62893-24-7 Purity >98.0 (HPLC) Cefoperazone Sodium Intermediate

Fmoc-Cys(Acm)-OH CAS 86060-81-3 Purity >99.0% (HPLC) Factory

CAS 102690-88-0 Bis(2-Cyanoethyl)-N,N-Diisopropylphosphoramidite Purity >98.0% (PNMR)

4-Methyl-3-Nitropyrazole CAS 38858-90-1 Purity >98.0% (HPLC)

L-4-Nitrophenylalanine Methyl Ester HCl CAS 17193-40-7 H-Phe(4-NO2)-OMe·HCl Assay >98.5% (HPLC) Factory

4-Methyl-3-Nitropyridine CAS 5832-44-0 Assay >98.0% (HPLC) Factory High Quality

α,α'-Dibromo-p-Xylene CAS 623-24-5 Purity >98.0% (GC)

2,2'-Dipyridyl Disulfide CAS 2127-03-9 Purity ≥99.5% Peptide Coupling Reagent Factory

4,5-Diamino-1-(2-Hydroxyethyl)pyrazole Sulfate CAS 155601-30-2 Purity >99.0% (HPLC)

Fmoc-Ser(HPO3Bzl)-OH CAS 158171-14-3 Fmoc-O-(Benzylphospho)-L-Serine Purity >98.0% (HPLC)

Yellow phosphorus and phosphoric acid rose together

The “Summit on COVID-19 Diagnostics & Treatment”

Xi presents award to top scientists

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

New COVID treatments offer hope

2022.08.09 00:09:43

2022.06.09 14:55:58

2022.05.03 06:14:33

2022.04.27 06:21:09

2021.11.05 05:08:00

2021.10.26 01:33:42

related search